Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer. Hojo Y, Tomita T, Igeta M, Murakami M, et al. Anticancer Res 2025;45:2091-2102.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hojo Y, Tomita T, Igeta M, Murakami M, et al. Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer. Anticancer Res 2025;45:2091-2102.
PMID: 40295068